SCHEMBL22014089

SCHEMBL22014089

C/C(=N\C(C)C)N1CCOCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.45
PKM P14618 1/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.37
CA12 O43570 3/20 0.37
CA1 P00915 3/20 0.37
CA9 Q16790 3/20 0.37
CA2 P00918 2/20 0.37
FAAH O00519 1/20 0.35
PHGDH O43175 1/20 0.35
ALDH1A1 P00352 1/20 0.35
ALDH2 P05091 1/20 0.35
PDK1 Q15118 1/20 0.35
PDK2 Q15119 1/20 0.35
PDK3 Q15120 1/20 0.35
MGLL Q99685 1/20 0.35
MEN1 O00255 1/20 0.34
TP53 P04637 1/20 0.34
KMT2A Q03164 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20706312 1.00 SMN1; SMN2 (0.45) SMN1; SMN2PKMLMNAMAPTCA12
SCHEMBL25753736 0.80 SMN1; SMN2 (0.42) SMN1; SMN2PKMLMNAMAPTCA12
SCHEMBL18763334 0.79 KMT2A (0.33) MAPTALDH1A1TP53KMT2ACYP3A4
SCHEMBL21674243 0.77 KMT2A (0.36) LMNACA12CA1CA9CA2
SCHEMBL17236378 0.77 KMT2A (0.36) LMNACA12CA1CA9CA2
SCHEMBL21534090 0.77 RECQL (0.31) PKMPOLB
SCHEMBL25753750 0.75 SMN1; SMN2 (0.43) SMN1; SMN2PKMLMNAMAPTCA12
SCHEMBL1105467 0.75 SMN1; SMN2 (0.50) SMN1; SMN2PKMLMNAMAPTCA12
SCHEMBL17236510 0.75 SMN1; SMN2 (0.50) SMN1; SMN2PKMLMNAMAPTCA12
SCHEMBL19861950 0.75 SMN1; SMN2 (0.50) SMN1; SMN2PKMLMNAMAPTCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662211-B2 Catalysts and methods for polymer synthesis Saurdi Aramco Technologies Company (SA) 2020-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662211-B2 Catalysts and methods for polymer synthesis PPOX, COASY, SOD1 SMN1; SMN2 4314/4885PKM 1104/4885LMNA 3764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.